Research Article

Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer

Figure 7

Association between the risk model and metabolic characteristics of pancreatic cancer (PC). (a) Enrichment analysis of 6 PAGs showed the potential metabolic pathways involved. (b) The expression levels of several KRAS-driven metabolic genes between high-risk and low-risk groups in TCGA cohort. Higher expressions of PKM (), GLUT1 (), HK2 (), LDHA (), and VDR () were found in the high-risk group.
(a)
(b)